Nilotinib: a novel Bcr-Abl tyrosine kinase inhibitor for...

Nilotinib: a novel Bcr-Abl tyrosine kinase inhibitor for the treatment of leukemias

Jabbour, Elias, El Ahdab, Samih, Cortes, Jorge, Kantarjian, Hagop
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Language:
english
Journal:
Expert Opinion on Investigational Drugs
DOI:
10.1517/13543784.17.7.1127
Date:
July, 2008
File:
PDF, 316 KB
english, 2008
Conversion to is in progress
Conversion to is failed